Back

Circulating plasma angiotensin-converting enzyme 2 concentrations in patients with kidney disease

European Heart Journal

20 July 2020
Organised by: Logo
Read full article
ESC Journals HEART FAILURE Chronic Heart Failure PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Insa M Schmidt
Insa M Schmidt

Author

Ashish Verma
Ashish Verma

Author

Boston Medical Center Boston , United States of America

Sushrut S Waikar
Sushrut S Waikar

Author

You may be interested in
thumbnail
Congress Presentation
Circulating ACE2 and the association of endothelial progenitor cell in CAD patients
1 September 2024
thumbnail
Congress Presentation
Renal and cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: A systematic review and meta-analysis
1 September 2019
thumbnail
Congress Presentation
Acute decompensated heart failure is a risk factor for acute kidney injury and a predictor of disease severity in hospitalized patients with COVID-19
29 June 2021
thumbnail
Congress Presentation
Cardioprotective effect of angiotensin converting enzyme 2 activation in hESC-derived cardiomyocytes under diabetic condition
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources